InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-11.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Musket David B, Director. Director active across 1 company, notably Capricor Therapeutics, INC.. Cumulatively, 8 disclosures have been published. Split: 3 buys · 2 sells. Total volume traded: €198k. History available since 27 December 2021. The latest transaction was disclosed on 7 August 2024 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Musket David B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
34,000 shares@ US$1.3914.4% of flowCommon StockSEC:0001415889-24-021022:0
16,156 shares@ US$1.397.0% of flowCommon StockSEC:0001415889-24-011416:0
410 shares@ US$2.750.4% of flowCommon StockSEC:0001415889-23-014199:0
Canonical exit: 10 Jan 2024 (T+90)
5,083 shares@ US$2.824.5% of flowCommon StockSEC:0001415889-23-014082:0
Canonical exit: 7 Jan 2024 (T+90)
2,500 shares@ US$2.902.3% of flowCommon StockSEC:0001415889-23-014031:0
Canonical exit: 2 Jan 2024 (T+90)
28,215 shares@ US$3.770.0061% mcap47.5% of flowCommon StockSEC:0001415889-22-007219:0
17,775 shares@ US$4.440.0045% mcap34.8% of flowCommon StockSEC:0001415889-22-007064:0
15,455 shares@ US$1.390.0011% mcap8.9% of flowCommon StockSEC:0001415889-21-006268:0
8 of 8 declarations
About Musket David B
David B. Musket is a Director at Capricor Therapeutics, Inc. In this role, he participates in the governance of the company and strategic decision-making. Capricor Therapeutics, Inc. specializes in medical treatments. David B. Musket brings his expertise to help guide the company's direction.
